J. Michael Hamilton, Chief Medical Officer at AVALON PHARMACEUTICALS INC (AVRX), bought 2,500 shares at $3.09 ($8K) on 2006-08-28, disclosed to the SEC on 2006-08-30.
Open-market purchase of $8k AVRX by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.